Annexin Imaging in Aortic Dissection

Phase 2, open-label, single-arm trial of technetium-tc99m-labeled annexin a5 in aortic dissection, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Correlation between the rate of expansion of the aortic diameter and the intensity of attachment of the annexin by the aortic wall descending at 30 months. Status: unknown.